Vision restoration after brain and retina damage: the "residual vision activation theory".
Bernhard A Sabel, Petra Henrich-Noack, Anton Fedorov...
https://pubmed.ncbi.nlm.nih.gov/21763527Actively Recruiting
Led by Adrian Guggisberg · Updated on 2026-04-29
14
Participants Needed
2
Research Sites
N/A
Total Duration
Visual field defects often occur after acquired brain injuries and can make daily activities like reading, driving, and moving around safely difficult. This research aims to evaluate whether neurofeedback therapy can improve vision in people with chronic visual field defects, particularly those who are at least 50 years old. The study builds on previous findings that neurofeedback can enhance brain communication and improve mobility after stroke, focusing here on visual ability such as visual field expansion and contrast sensitivity. Participants will undergo neurofeedback training using high-density EEG and advanced brain signal analysis to provide real-time audio feedback. During the active phase, patients receive feedback linked to brain activity in visual areas to help improve brain connectivity. The control phase uses synthetic feedback that mimics real feedback but is not linked to actual brain activity. Each training session lasts about 40 minutes with breaks and is followed by visual stimulation of the affected visual field designed to promote steady-state visual evoked potentials. Throughout the study, researchers will measure changes in the visual field at 3 weeks and 7 weeks, along with changes in alpha-band brain connectivity, the impact of visual impairment on daily life via questionnaires, and reading speed. The study uses a randomized, double-blind design and includes monitoring to assess how neurofeedback affects vision and brain function over the treatment period. Participation is expected to last at least 7 weeks from enrollment through follow-up.
CONDITIONS
Neurofeedback-based Visual Restoration Therapy
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 weeks
Participants undergo neurofeedback training sessions to learn to improve brain connectivity related to their visual field defects. Each training lasts about 40 minutes with frequent breaks, followed by visual stimulation of the affected visual field. Participants experience both active and control phases in a randomized crossover design.
Multiple sessions during the 3-week treatment period
Duration - 4 weeks
Participants are assessed to measure changes in visual field, functional connectivity, daily-life impact, and reading speed after the treatment period.
1 follow-up visit at 7 weeks post enrollment
Total: 2 locations
1
Inselspital
Bern, Canton of Bern, Switzerland, 3010
Actively Recruiting
2
Division of Neurorehabilitation, University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland, 1202
Not Yet Recruiting
A
Adrian Guggisberg, MD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Bernhard A Sabel, Petra Henrich-Noack, Anton Fedorov...
https://pubmed.ncbi.nlm.nih.gov/21763527Anaïs Mottaz, Tiffany Corbet, Naz Doganci...
https://pubmed.ncbi.nlm.nih.gov/30112275Leslie Allaman, Anaïs Mottaz, Andreas Kleinschmidt...
https://pubmed.ncbi.nlm.nih.gov/33158966Leslie Allaman, Anaïs Mottaz, Adrian G Guggisberg
https://pubmed.ncbi.nlm.nih.gov/34284245